Nutraceuticals May Treat Negative Symptoms of Schizophrenia Nutraceuticals May Treat Negative Symptoms of Schizophrenia

New randomized control trials show signs of the potential benefit of herbal and nutraceutical agents as adjunctive treatment for the negative symptoms of schizophrenia.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Source Type: news

Related Links:

Fernanda F. Peres, Mariana C. Diana, Raquel Levin, Mayra A. Suiama, Val éria Almeida, Ana M. Vendramini, Camila M. Santos, Antônio W. Zuardi, Jaime E. C. Hallak, José A. Crippa, Vanessa C. Abílio
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
The X chromosome has long been an intriguing site for harboring genes that have importance in brain development and function. It has received the most attention for having specific genes underlying the X-linked inherited intellectual disabilities, but has also been associated with schizophrenia in a number of early studies. An X chromosome hypothesis for a genetic predisposition for schizophrenia initially came from the X chromosome anomaly population data showing an excess of schizophrenia in Klinefelter ’s (XXY) males and triple X (XXX) females. Crow and colleagues later expanded the X chromosome hypothesis to incl...
Source: Molecular Neuropsychiatry - Category: Neuroscience Source Type: research
Brainsway, Israel’s leading magnetic stimulation company, won FDA de novo clearance for its system to be used to treat obsessive compulsive disorder (OCD) in the United States. The company’s Deep Transcranial Magnetic Stimulation sys...
Source: Medgadget - Category: Medical Devices Authors: Tags: Neurology Psychiatry Source Type: blogs
Sai Ma, former Virginia Tech biomedical engineering Ph.D. student, and Chang Lu, the Fred W. Bull professor of Chemical Engineering at Virginia Tech. Credit: Virginia Tech ___ Epigenetic Changes Guide Development of Different Brain Regions (Dana Foundation): “It’s one of the greatest standing mysteries in neuroscience: Given that each cell in the human body contains the same DNA, how, exactly, does the brain develop into distinct functional regions, supported by different cell types? And how might that developmental program go awry, resulting in neurodevelopmental disorders like schizophrenia or autism? The ans...
Source: SharpBrains - Category: Neuroscience Authors: Tags: Cognitive Neuroscience Education & Lifelong Learning Health & Wellness Technology bioengineering brain cerebellum clinical disorders DNA epigenome Neurodevelopmental neurodevelopmental disorders neurological neuropsychiatric Source Type: blogs
Publication date: Available online 20 August 2018Source: Journal of Psychiatric ResearchAuthor(s): Wei Zheng, Dong-Bin Cai, Xin-Hu Yang, Lu Li, Qing-E. Zhang, Chee H. Ng, Gabor S. Ungvari, Xian-Bin Li, Yu-Ping Ning, Yu-Tao Xiang
Source: Journal of Psychiatric Research - Category: Psychiatry Source Type: research
 Mania has an odd place in our society. For people who have not experienced it, it’s seen has as exciting, productive, and desirable. For those of us who have been consumed by it, we are either thankful it isn’t depression or devastated by its impact. For most, mania is a dangerous symptom of mental illness and not something to be taken lightly. In this episode, Gabe &Michelle each share three stories about mania with two being the truth and one being a lie. Can you tell fact from fiction? Listen now.   SUBSCRIBE &REVIEW           “When I’m manic, I...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: A Bipolar, A Schizophrenic, and a Podcast Disorders Mania Schizophrenia Source Type: blogs
(University of North Carolina Health Care) For the first time, scientists have figured out why drugs that aim to treat Parkinson's disease, migraines, pituitary tumors, and obesity activate the serotonin receptor 5-HT2B to cause life-threatening heart problems. Published in Nature Structure&Molecular Biology, this research provides drug developers with much needed insights into serotonin receptors -- insights that should help scientists create safer more effective drugs, not just for the aforementioned conditions, but also depression, anxiety, and schizophrenia.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news
Psychiatric Services, Ahead of Print.
Source: Psychiatric Services - Category: Psychiatry Authors: Source Type: research
czor Schizophrenia is a debilitating mental illness which involves three groups of symptoms, i.e., positive, negative and cognitive, and has major public health implications. According to various sources, it affects up to 1% of the population. The pathomechanism of schizophrenia is not fully understood and current antipsychotics are characterized by severe limitations. Firstly, these treatments are efficient for about half of patients only. Secondly, they ameliorate mainly positive symptoms (e.g., hallucinations and thought disorders which are the core of the disease) but negative (e.g., flat affect and social withdraw...
Source: Molecules - Category: Chemistry Authors: Tags: Review Source Type: research
This article describes the approach to training and implementing the NAVIGATE program at the 17 sites (including 134 practitioners) randomized to provide it, and to evaluating the fidelity of service delivery to the NAVIGATE model. Fidelity was evaluated to five different components of the program, all of which were standardized in manuals in advance of implementation.
Source: Schizophrenia Research - Category: Psychiatry Authors: Source Type: research
More News: Complementary Medicine | Health | Herbs | Psychiatry | Schizophrenia